CIK 0000771856 · Non-accelerated filer<br>Smaller reporting company
CHAMPIONS ONCOLOGY, INC.
Sign in to watch- Ticker
- CSBR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521401755
- Phone
- 410-369-0365
- Business address
- 855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 21205
- Former names
- CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-26 | Mendelson Daniel Newman Director | Purchase | +700 | $5.90 | $4K | 58,446 |
| 2020-03-26 | Mendelson Daniel Newman Director | Purchase | +300 | $5.89 | $2K | 58,746 |
| 2020-03-24 | Mendelson Daniel Newman Director | Purchase | +26 | $5.50 | $143 | 57,526 |
| 2020-03-24 | Morris Ronnie CEO | Sale | −75 | $5.25 | $394 | 837,168 |
| 2020-03-20 | Morris Ronnie CEO | Purchase | +75 | $4.75 | $356 | 837,243 |
| 2020-03-11 | Morris Ronnie CEO | Option exercise | +124,232 | $5.76 | $716K | 961,400 |
| 2020-03-11 | Morris Ronnie CEO | Option exercise | +2,708 | $4.80 | $13K | 964,108 |
| 2020-03-11 | Morris Ronnie CEO | Option exercise · Warrant to purchase shares of Common Stock | −124,232 | $5.76 | $716K | 0 |
| 2020-03-11 | Morris Ronnie CEO | Option exercise · Warrant to purchase shares of Common Stock | −2,708 | $4.80 | $13K | 0 |
| 2020-03-11 | Battery Ventures IX, L.P. 10% owner | Option exercise | +123,333 | $4.80 | $592K | 2,135,215 |
| 2020-03-11 | Battery Ventures IX, L.P. 10% owner | Option exercise | +286,458 | $5.76 | $1.6M | 2,421,673 |
| 2020-03-11 | Battery Ventures IX, L.P. 10% owner | Option exercise · Warrant to purchase shares of Common Stock | −123,333 | 0 | ||
| 2020-03-11 | Battery Ventures IX, L.P. 10% owner | Option exercise · Warrant to purchase shares of Common Stock | −286,458 | 0 | ||
| 2020-03-06 | New Enterprise Associates 14, L.P. 10% owner | Option exercise | +859,375 | $5.76 | $5.0M | 2,421,875 |
| 2020-03-06 | New Enterprise Associates 14, L.P. 10% owner | Sale | −708,155 | $6.99 | $5.0M | 1,713,720 |
| 2020-03-06 | New Enterprise Associates 14, L.P. 10% owner | Option exercise · Warrant to Purchase Common Stock (right to buy) | −859,375 | 0 | ||
| 2020-03-03 | ACKERMAN JOEL Director | Option exercise | +124,232 | $5.76 | $716K | 1,441,220 |
| 2020-03-03 | ACKERMAN JOEL Director | Option exercise | +2,708 | $4.80 | $13K | 1,443,928 |
| 2020-03-03 | ACKERMAN JOEL Director | Option exercise · Warrant to purchase shares of Common Stock | −124,232 | $5.76 | $716K | 0 |
| 2020-03-03 | ACKERMAN JOEL Director | Option exercise · Warrant to purchase shares of Common Stock | −2,708 | $4.80 | $13K | 0 |
Page 7 of 20 · 398 trades